Gaucher Disease Types 2 and 3

Unlike Gaucher disease type 1, Gaucher disease types 2 and 3 have early onset brain involvement that gets worse over time. For this reason, Gaucher disease types 2 and 3 are known as neuronopathic Gaucher disease. Currently, there is no effective treatment for the severe brain involvement associated with Gaucher disease types 2 and 3.

Gaucher Disease Type 2

Gaucher disease type 2 (also called acute infantile neuronopathic Gaucher disease) has the earliest onset of all Gaucher disease types. Symptoms first become apparent within the first 3 to 6 months of life. It is fatal, usually causing death before 2 years of age.

Gaucher disease type 2 signs and symptoms include early onset brain damage that is severe and rapidly worsening. Other signs include:

  • Poor development
  • Seizures
  • Spasticity (jerking movements)
  • Poor ability to suck and swallow
  • Enlarged liver and spleen

Due to their shortened lifespan, babies with Gaucher disease type 2 do not survive long enough to develop other typical Gaucher disease symptoms like bone involvement. Some can be stillborn or have severe skin abnormalities.

Gaucher Disease Type 3

Gaucher disease type 3 (also known as chronic neuronopathic Gaucher disease) may be the most common type worldwide. It is more common than type 1 in the Middle East, India, China and the Pacific Rim.

Gaucher disease type 3 has a later and more gradual onset compared with type 2. People with Gaucher type 3 disease may survive into adulthood with a wide variety of signs and symptoms.

Major signs include:

  • Seizures
  • Skeletal irregularities
  • Eye movement disorders
  • Cognitive problems
  • Poor coordination
  • Enlarged liver and spleen
  • Respiratory problems
  • Blood disorders

Treatment for Gaucher Disease Types 2 and 3

There is currently no effective treatment for Gaucher disease type 2. Patients with Gaucher disease type 3 can receive enzyme replacement therapy (ERT) to address symptoms not involving the brain, like organ enlargement and bone issues.

ERT works well to control complications that most commonly occur in patients with Gaucher disease type 1. However, the replacement enzyme does not cross the “blood-brain” barrier, which acts to protect the brain but also filters out medications. Therefore, enzyme replacement has little to no effect on the severe brain involvement associated with Gaucher disease types 2 and 3.

Learn more about enzyme replacement therapy for Gaucher disease and other Gaucher disease treatment options.

Gaucher Disease Types 2 and 3 Resources

To learn more about Gaucher disease types 2 and 3 or to connect with others, you can join the Gaucher disease Type 2 and 3 discussion list. You will need to sign up for a Yahoo mail account, and an administrator of the group will need to approve you to join.

Stay in Touch with NGF

Learn about the latest research, news and events.